ENGELHARDT EVA ANETTE 4

What Happened
Eva Anette Engelhardt, EVP and President, CDG of BIO-RAD LABORATORIES, INC. (BIO), sold 550 shares in an open-market transaction on May 11, 2026. The shares were disposed at $246.54 each, generating proceeds of approximately $135,597. This was a sale (code S); sales by executives are common and do not by themselves indicate a change in sentiment.

Key Details

• Transaction date: 2026-05-11 (open-market sale)
• Price per share: $246.54; total proceeds ≈ $135,597
• Filing date / accession: Form 4 filed 2026-05-13 (Accession No. 0002024911-26-000002) — filed within two business days of the trade (timely)
• Shares owned after transaction: Not specified in the provided filing
• Footnotes/plan: The filing does not disclose a 10b5-1 plan, tax-withholding, or other special instructions for this sale

Context
Sales by company officers can be routine (diversification, liquidity, tax planning) and are not direct proof of company prospects. Retail investors should view this single, modest-sized sale in the context of other insider activity and company fundamentals.